Stay updated on 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page.

Latest updates to the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page
- Check6 days agoChange DetectedRecruitment status is updated to 'No longer looking for participants', indicating enrollment for the study is closed. The page also adds or updates navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision to v3.6.0.SummaryDifference0.6%

- Check13 days agoChange DetectedMultiple myeloma was added as a condition and MedlinePlus Genetics was added as a related topic. The revision tag was updated from v3.5.4 to v3.5.5.SummaryDifference0.2%

- Check21 days agoChange DetectedThe page no longer displays the disease keyword and its related topics section, removing access to the associated resources for this condition.SummaryDifference0.2%

- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe study page now lists 'Multiple myeloma' as a condition and includes related topics such as MedlinePlus Genetics, expanding navigational context for readers. The site revision was updated to v3.5.4, replacing the previous v3.5.3.SummaryDifference0.2%

- Check49 days agoChange DetectedA new revision tag v3.5.3 appears. Related topics including Multiple myeloma and MedlinePlus Genetics were removed from the related topics section.SummaryDifference0.2%

- Check56 days agoChange DetectedAdded related reference topics for “Multiple myeloma” including MedlinePlus Genetics.SummaryDifference0.2%

Stay in the know with updates to 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page.